Steve O'Loughlin
Directeur Financier/CFO chez ACTINIUM PHARMACEUTICALS, INC.
Fortune : 7 760 $ au 30/04/2024
Postes actifs de Steve O'Loughlin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 15/05/2017 | - |
| Directeur Financier/CFO | 15/05/2017 | - | |
| Investor Relations Contact | - | - | |
| Corporate Officer/Principal | 13/10/2015 | 15/05/2017 | |
| Secrétaire Général | 15/05/2017 | - |
Historique de carrière de Steve O'Loughlin
Anciens postes connus de Steve O'Loughlin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 01/08/2012 | 01/06/2015 |
Formation de Steve O'Loughlin
| Ramapo College of New Jersey | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Commercial Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
- Bourse
- Insiders
- Steve O'Loughlin
- Expérience
